chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Itchy eyes the day of vaccine. Developed itchy rash and hives the following day and hives on trunk, neck, and now a few on my legs and arms. Have continued for 2 weeks, just now getting better. I have not had a reaction to any previous vaccine and do not have an egg allergy.
Information has been received from a doctors office concerning a female who was vaccinated with MMR at a different doctor's office. There was no illness at the time of vaccination. Subsequently the patient experienced a lesion. Subsequently, the patient recovered from lesion with topical steroid use. Unspecified medical attention was sought. The reporter stated that in no way [is she] saying this was a fixed drug reaction nor was it due to MMR. No further information is expected.
Patient hospitalized due to COVID-19. Patient is fully vaccinated. Patient had fever, cough, shortness of breath.
Patient was signed up to receive Pfizer vaccine when making the appointment online at ; however, our clinic  had not yet started administering Pfizer, only Moderna. Father stated Moderna was ok to give. Administrating provider did not realize the patient was less than 18 years old.  No known adverse symptoms occured.
Ma administered TDAP with polio on 15 month old patient instead of due TDAP.  No side effects in patient.
This case described the occurrence of fever in a 4 month old male patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine and hepatitis B vaccine for prophylaxis. This report was initially received from the patient's mother. On 11/25/03, follow up was received from a nurse. On 9/22/03, the patient received injections of diphtheria and tetanus toxoids and acellular pertussis vaccine, hepatitis B vaccine, Haemophilus influenzae type B conjugate vaccine, inactivated poliomyelitis virus vaccine, and 7-valent pneumococcal conjugate vaccine. Later that day, at an unspecified time post immunization, the patient experienced slight fever and fussiness. The events resolved on 9/27/03. The nurse considered the events to be unrelated to vaccination with diphtheria and tetanus toxoids and acellular pertussis vaccine and hepatitis B vaccine.
expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) in a 45-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). On 22-Nov-2021, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The pharmacist called about administration of expired Moderna vaccines tat was given as booster shot to patients around 490 to 500 on the last date 20 -Oct -2021 to 29-Nov-2021. No concomitant medication information was provided.  No treatment medication information was given
patient developed injection site reaction after receiving PNEUMOVAX 23; he patient's arm was swollen; warm to the touch; This spontaneous report was received from an other health professional and refers to a 38-year-old male patient. There was no information about the patient's concurrent conditions or medical history provided. Concomitant therapies included cobicistat (+) elvitegravir (+) emtricitabine (+) tenofovir alafenamide fumarate (GENVOYA), hydrochlorothiazide (HCTZ) and lisinopril.  On 02-AUG-2023, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) lot #w007035 was valid, expiration date established as 20-OCT-2023 (exact dose, route of administration, anatomical location not provided) for prophylaxis.  On 03-AUG-2023, the patient experienced injection site reaction (vaccination site reaction). The patient's arm was swollen and warm to the touch (vaccination site warmth) (vaccination site swelling). The outcome of vaccination site reaction, vaccination site warmth and vaccination site swelling was reported as recovering/resolving. The patient was Sought Medical Attention, saw a physician and received doxycycline, diphenhydramine hydrochloride (BENADRYL) and prednisone as a treatment.  Causal relationship between events and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was unknown.
Patient received Pneumovax in left arm and high dose fluzone in right arm on 9/11.  That evening the left arm became swollen and sensitive/painful to touch.  on the evening of 9/12 she presented to pharmacy with bruising at the injection site of the left arm (pneumovax) and redness/swelling going down the arm around the elbow.
Fever of 105, resulted in seizure. Fever lasted 48 hours. Then rash breakout.
red itchy hot rash appeared within 30 mins of shot, face brought out in bright red rash. I have actually broken out since this shot 5 more times the same way. I start getting warm and feel it coming on and within 10 mins of that feeling I am completely broken out and it lasts over 1 hour with taking benedryl. The rash comes and goes now and I had Epsten Barr Virus exposure in the military, so not sure but it feels like it trigger something in my body now.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Feb2021 as dose 2, single (Batch/Lot number: unknown) at the age of 74 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Lyme disease" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Cipro, reaction(s): "known allergies: cipro"; Rocephin, reaction(s): "known allergies: rocephin". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Anti viral details: product: COVID 19 Treatment, brand: PAXLOVID, treatment start date: 31Aug2022, treatment stop date: 05/Sep/2022  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Swelling of arm, took 25 mg of Benadryl and subsided.
The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from the practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 30-APR-2018, the patient was vaccinated with an improperly stored dose of M-M-R II (strength was unknown) (lot# M034856 and expiration date 27-JUL-2018) subcutaneously for prophylaxis. The MERCK STERILE DILUENT was properly stored. No adverse event was reported. The excursion temperature on 22-SEP-2017, 17-OCT-2017, 06-DEC-2017, 07-DEC-2017; 30-JAN-2018, 23-FEB-2018, 18-MAY-2018, 07-JUL-2018, 15-AUG-2018 was 6 degree Celsius for maximize 8.75 hours. The excursion temperature on 02-MAR-2018, 27-AUG-2018 was 7 degree Celsius for maximize 8.75 hours. The excursion temperature on 07-DEC-2017 was 8 degree Celsius for maximize 15 hours. The call was not because of data logger. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1809USA003709: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001956: US-009507513-1810USA001957: US-009507513-1810USA001958.
This spontaneous case, initially received from non-health professional on 31-Oct-2018, concerns a 62-year-old, elderly female patient. The patient's current condition included diabetes, hypercholesterolemia, hypothyroidism and anxiety (reported as medical history). The patient was allergic to pickles. The patient's concomitant medications included insulin, VICTOZA, metformin, TOUJEO, WELCHOL, JARDIANCE, LIPITOR, levothyroxine, EFFEXOR and aspirin for unknown indications. On 30-Oct-2018, the patient was administered an expired vaccine FLUCELVAX QIVc [dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 195246 and expiry date: 30-Jun-2018]. No adverse event was reported after administration of the vaccine. The reporter assessed this case as non-serious.
Vaccine use by date was 12/12/21, vaccinated 12/13/21.
This spontaneous report was received from a registered nurse, and refers to an unspecified number of patients of unknown age and gender. The patients' pertinent medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not reported. On unspecified dates, the patients were vaccinated with improperly stored doses of M-M-R II, lot # L035674, 0.5 ml, expiration date 17-SEP-2017, and/or lot # L034731, expiration date 09-SEP-2017, (dose, dose number, route, and anatomical location were unspecified). The reporter stated that the vaccines were exposed to 5.5F during 10 minutes. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
pt recvd vax in 1990 & 26OCT92 lab eval showed a neg rubella antibody; No further details were provided;
Constant electric skin pulses throughout all of my body. On certain days, more than others days. Did not realized it was the vaccine until August 4-6, 2019. Vent to my Internist on 8/7/2019. Went to Neurologist on 8/8/2019. Will have EMG on 9/11/209 (upper Body) and 9/19/2019 (Lower Body) Results for EMG on 9/23/2019.
PT PASSED OUT AFTER 5 MINUTES OF GETTING VACCINE. BLACKED OUT FOR 30 SECONDS, CALL 911,  PARAMEDICS TOOK TO HOSPITAL
The pt had a seizure several hours after the vaccination. The pt went to a hospital ER.
Severe swelling of both injection sights within 24-48 hours of administered dose. Developed Guttate Psoriasis within 2 weeks of first dose, limited to the arm of where the vaccines were administered. Full body Guttate psoriasis developed within 1 week of second dose to include scalp, nose, shoulders, arms, chest, back, groin, legs and feet. Severe itching all over body.
Patients have been administered doses while the temperature excursion assessment was ongoing; Patients have been administered doses while the temperature excursion assessment was ongoing; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported. No adverse reactions were reported by the patient.
the next day I woke up with a headache, slight fever (99.8)  fatigue and discomfort, which lasted the entire day. The second day seems much better, with
Pt with extreme anxiety complained of faintness post injection and sharp pain in head which resolved shortly. Had itchy, red area approx 2 x 6 inches at injection site for 3-4 days. No swelling or fever. Resolved spontaneously.
30 minutes after taking flu shot and 2 Tylenol ears flushed, neck started itching no shortness of breath, cool compress applied, 30 min later creases of both arms red, no itching ice pack applied, 30 mins later, ear redness, redness on neck gone. 45 mins later took 50 mg Benadryl 1 hour later no itching or redness.
about 5 to 10 minutes after vaccination, customer presented seizure/convulsion like symptoms, appeared dazed, eyes were open but limited response or verbalization.  Referred to Emergency Room for medical examination.
Patient received vaccine out of the recommended age rage at age 17. No adverse events reported. Reports mild pain to injection site for 1-2 days, no other side effects.
This spontaneous report as received from a registered nurse refers to a patient (age and gender not provided). The patient's medical history included smoking. On unknown date, the patient was vaccinated with PNEUMOVAX 23 (route, dose and lot number not provided). No other co-suspects were reported. No concomitant medications were reported. On an unknown date, the patient's arm swelled at the site of injection. No treatment information was reported. The outcome of patient's arm swelled at the sit eof injection was unknown. The relatedness for patient's arm swelled at the site of injection was unknown for PNEUMOVAX 23. Additional information has been requested.
patient complains of itching inside throat and need to keep clearing throat soon after receiving 2nd dose of vaccine. symptoms relived few minutes after Benadryl 50 mg IM dose given. at 1800 patient was discharged home symptoms free in stable condition. boyfriend with patient. follow-up care instructions given to both.
Information has been received from a registered nurse, concerning her 5 year old son, who on 12-MAY-2004 was vaccinated with VARIVAX (Oka/Merck). On 21-FEB-2007, the patient was vaccinated with MMR II (+) VARIVAX (Oka/Merck upgrade process). (MSD). On 20-AUG-2008, the patient developed a mild case chickenpox. The child had about 50 lesions and a fever of 100.1F. The patient was treated with BENADRYL and AVEENO baths as needed. At the time of report, the patient had not recovered. The patient sought medical attention in the office. There was no product quality complaint. Additional information has been requested.
Patient states her arm hurt from her Prevnar vaccine to the point she can no longer lift her arm. Patient has has tried heat, cold, Tylenol, ibuprofen, and profession massage, and arm still hurts to the point she can no lift it on her own. Patient reported to the pharmacy on 9/15/2015 her symptoms and was advised that if symptoms continue, she should seek additional medical attention.
At 1:30 am the following day, I woke up with pain in my left arm. I felt sick. I got clammy and dizzy. I was shaking in both arms.  I got really hot and passed out. When I came to, I had lost all control of bodily function and my mouth was really dry.
This is a 60-year-old male patient with a known medical history of hypertension, diabetes, previous stroke, factor 5 Leiden who presented to the ED with reports of multiple falls over the last couple days as well as increased weakness and poor p.o. intake as well as slurred speech and unresponsiveness on presentation. Patient was found to have a glucose level of 41 upon presentation, was given D50 in ED went up to 121.  Also has found to be COVID positive as well as with acute kidney injury creatinine 1.72/BUN 41.  Patient reports that over the last 2 weeks he has had a few falls and overall weakness. He admits to a CVA in the past with residual left-sided weakness although this has significantly improved over the last several years.  He does present with hypotension on multiple antihypertensive medications which could be contributing to his falls.  Patient otherwise denies any recent fevers, chills, cough chest pain, palpitations, abdominal pain, nausea, vomiting or dysuria.  Tested positive on 8/23/2021
First dose no adverse effects (none)... Second dose on May 15.  Several days later on May 20 I developed a cough. By the weekend there was chest pain and difficulty breathing.  For the next several days, lung (or back pain); constant coughing and wheezing.  I happen to have perscription steroids at hand (for my Lupus).  I increased the amount of prednisone from the 20mg I've been on for the past 30 years to anywhere from 35mg to 50mg as needed to alleviate the breathing difficulty.  This lasted for 4 weeks.  These last several days I am better ( since past Friday, June 18) I have been able to wean myself off prednisone to my regular 20mg without recurrence of cough/wheezing (so far so good).  Still get out of breath when I exert myself physically:  heart rate elevated and shortness of breath.
(L) arm pain, Redness, Swelling + tingling gradually improving over last 24 hrs
Extreme fatigue that lasted over 24 hours, mild fever, headaches, sore throat (started over 24 hours after vaccine), chills
On November 21st, I travelled out of state, so about 2 months after taking the vaccine. I went to a farmer's market, and I felt like I was getting a sinus infection. My mucus was clear. The next day I had mild chills, and maybe a slight fever, and the next day, I felt aching. I started taking a supplement that had golden seal in it. I believed I had a sinus infection or had one coming on. I had tested for COVID and it was negative. On Friday I went to urgent care and told them I took a Covid test and it was negative. So they did not do a Covid test, but they did a flu test. It was negative, so they told me to take TYLENOL and over the counter medication for a cold virus. 2 days later my daughter that I was staying with tested COVID. It took me around 10 days to feel completely back to normal.
This case was reported by a consumer via call center representative and described the occurrence of headache in a 70-year-old male patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of headache (Notes-Headache and muscle ache after receiving 1st dose on 24th May 2018, see case US2018151975). On 20th August 2018, the patient received the 2nd dose of SHINGRIX. On an unknown date, 4 hrs after receiving SHINGRIX, the patient experienced headache, muscle pain and general body pain. On an unknown date, the outcome of the headache and muscle pain were recovered/resolved and the outcome of the general body pain was unknown. It was unknown if the reporter considered the headache, muscle pain and general body pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter reported headaches and body ache after both doses. It showed up within 4 to 5 hours. The patient received his second shot of SHINGRIX on 20th August 2018 and he got a headache about 4 to 5 hours after the shot. The headache had been continued and had not yet resolved. The caller also reported that he was experiencing mild tolerable body or muscle aches that had not resolved till the reporting date. This case has been linked with US2018151975, reported by the same reporter for the same patient.
Moderna COVID-19 Vaccine EUA  My symptoms involved my spinal cord, spasms traveling up and into my neck and head.  It increased my lymph fluid and flared up my menieres disease.  I had painful headaches throughout my face.  My occipital glands were inflamed.  when I would stand after sitting the spasms would travel and then my neck felt like it was being squeezed, my hearing would fade and I would almost pass out.  I couldn't sleep at night because of the pain.  after one week, my doctor prescribed a medrol pack.  After 6 days the symptoms returned.  I ended up in Emergency.  they gave me injections of both valium and Toradol.  then my doctor put me on 12 more days of prednisone.  I have completed it but still am struggling with the spasms in my neck.
Starting about 13 hours after injection, abdominal pain, cramping, nausea, upset stomach, upper stomach pain.  Woke up 31 hours after injection with fever (100 F) and abdominal pain.   Abdominal pain continuing throughout day and night since (now 6 days after).  Loss of appetite, Continued pain in upper stomach.  Just had blood labs taken to check pancreas.  Labs not received yet.
Systemic: Lymph Node Swelling-Medium, Additional Details: Pt presented to the pharmacy with swollen lymph nodes on her left underarm and left side of the neck
Patient showed up and showed us her arm today 9/23/2019.  It was red at the location of the shot. She said it was itchy and hot.  She was advised to follow up with Dr whose information was provided in this form (her primary care doctor). We do not know if the patient will follow up with the doctor or not. We do not know the outcome.
No adverse events that we are aware of. We input the vaccine in our state registry, agency, last night. We discovered that the patient had already received a Janssen vaccine 03/06/2021 at a different facility when we saw his record in the agency. We gave the patient first dose of Moderna 06/29/2021.
Some patients received SQ instead of IM; This case was reported by a other health professional via call center representative and described the occurrence of intramuscular formulation administered by other route in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix (subcutaneous). On an unknown date, unknown after receiving Shingrix, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the intramuscular formulation administered by other route was unknown.  Additional details were provided as follows: The age at vaccination was not applicable to this report. The reporter stated that, some patients received doses of Shingrix subcutaneously (SQ) instead of intramuscularly (IM), which led to intramuscular formulation administered by other route. No further details provided. The reporter submitted all information per web form received.No additional details available. The reporter consented to follow-up.
Temporary use of benadryl cream and pills, along with aloe. Ultimately, best solution was topical steroid cream
pt recvd vax; on 29jul95 devel a rash on chest, stomach & back; reporter stated it could poss have been a heat rash;
Developed Erythema multiforme minor 7 days after receiving PROQUAD and PREVNAR 13. Tx: systemic steroid, Antihistamine, Ranitidine.
pt recvd vax; pt became flush, dizzy & felt hot; exp nausea & quickly became chilled & clammy to touch; pt had difficulty concentrating; devel migraine;
They started in the afternoon. I thought I was getting dizzy. I was working and thought the computer was moving. I thought that eating something would help but then the room started spinning and I was vomiting for the next 4-5 hours and nausea. My doctor suggested that it was migraine related since they are episodic. My eyes were hurting and I couldn't eat anything. The entire week all I ate was Jello and chicken broth. She had me take Advil, Zofran, Benadryl. It helped with the dizziness and I slept through the night. These symptoms have never happened with my migraines.